Clinical Utility of Fast Comprehensive Genomic Profiling (CGP) in Solid Tumours

https://www.medscape.com/medicalaffairs/443484.2/media-1 Biomarker testing is the cornerstone of precision oncology, allowing patients to get access to biomarker-associated therapies. In this video, Dr Nicola Normanno discusses the importance of biomarker testing, focusing on comprehensive genomic profiling (CGP) for patients with solid tumours. This resource explores the current clinical guidelines on the use of next-generation sequencing (NGS) and key real-world insights on the use of CGP in patients with advanced solid tumours. Additionally, Dr Normanno outlines the performance of CGP in clinical practice, highlighting the impact of fast turnaround times. In which clinical scenarios does CGP bring value to clinical decision-making? Watch this video to find out.